Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Capitol Connections Article [Letter Trifecta] [08.26.13]
Share |

Member Alert: Letter Trifecta

IACP is aware of the three letters currently circulating to our members - the Aptalis Pharma letter regarding RECTIV, the Arnall Golden Gregory letter regarding Mitosol, and the Express Scripts letter stating that compounded drugs using bulk chemicals will no longer be covered.
 
 
 
 
IACP will be sending all members an email and fax on how to handle these specific letters. In the meantime, please visit IACP's AdvanCE self-paced webinars on our website. Click here to access IACP's webinar, Sound & Fury: Responding to Manufacturers’ Cease & Desist Letters.

This webinar will answer your questions, “What should I do? Ignore it? Send it to my attorney? Comply with their request? Why did I get this in the first place? Who are these people anyway?” This program will help you understand what a “cease-and-desist” letter is, where it comes from, what it means, and what to do about it. Stay tuned for more information to come.
 

 

Association Management Software Powered by YourMembership.com®  ::  Legal